en / fr
  • Investors
  • Entrepreneurs
  • Joining our team
Logo Seveture
  • About
    • About Seventure
    • Our Investment Strategy
    • Our Portfolio
    • Our Team
    • Regulatory policies
    • ESG Commitments
  • Our Expertise
  • Products
    • Our FCPI
    • Our Institutional Funds
  • News
  • Contact us
  • Investors
  • Entrepreneurs
  • Joining our team
en / fr

Search

Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week
9 May 2023

Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week

  • Life Sciences
  • Microbiome / Nutrition / Foodtech / Lifestyle

Exploratory analyses from the VE303 Phase 2 CONSORTIUM study identify statistically significant relationships between VE303 bacterial species and multiple parameters that...

Read the press release

Seventure Partners

5 - 7 Rue de Monttessuy

75340 Paris Cedex 07

+33 1 57 95 05 10

Entrepreneurship is an adventure

  • About
  • Products
  • News
  • Contact us

Follow us

Groupe BPCE

Legal notice | © Seventure 2023